Novavax (NVAX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

In this article, we are going to take a look at where Novavax, Inc. (NYSE:NVAX) stands against other under-the-radar stocks. Investing in under-the-radar stocks can be a savvy move for those ...

Eduardo Valdivia, 40, of Gaithersburg was arrested by county police in Greenbelt in November. He was indicted Thursday on a total of 19 counts, including eight counts of second-degree rape ...

I have been warning about Novavax's risks since 2016, highlighting its ongoing struggles with the FDA. Novavax's Q3 2024 earnings call and 10-Q reveal a collaboration negotiated from a position of ...

Novavax (NVAX) ended the recent trading session at $8.55, demonstrating a +0.53% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily gain of 1.83% ...

A 15-year-old boy was arrested and charged with armed robbery and assault in Gaithersburg after Montgomery County police utilized a drone to respond to the alleged incident on Friday, police said ...

These make five multifamily deals north of $100M we've reported on in just the last few weeks. Sentinel Real Estate Corp. recently bought two big apartment communities in Tysons and Gaithersburg ...

These are jabs developed by Pfizer Biontech, Moderna and AstraZeneca. While the Novavax and the Sanofi GSK vaccines will not be part of the module, it will look at the circumstances surrounding ...

Shares of Novavax declined after the company reaffirmed full-year revenue and fellow vaccine maker Moderna lowered its guidance. Novavax stock was down 7.3%, to $8.64, on Monday but is up about 89 ...

As you can see from the chart above the percentage of shares that are sold short for Novavax has declined since its last report. This does not mean that the stock is going to rise in the near-term ...